Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regeneron Pharmaceuticals
Biotech
Regeneron shares updated data on hearing loss gene therapy
Regeneron posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness.
Nick Paul Taylor
Oct 12, 2025 10:18am
Regeneron's ultrarare disease phase 3 hits, teeing up filings
Sep 17, 2025 9:31am
Regeneron antibodies post ph. 3 wins against cat, pollen allergy
Sep 8, 2025 9:54am
'Several concerning observations': FDA sheds light on rejections
Sep 5, 2025 10:45am
Nykode bets future on cancer trial after losing Genentech pact
Aug 27, 2025 8:25am
Regeneron posts phase 3 win, advancing push to muscle in on gMG
Aug 26, 2025 9:41am